November 1, 2016 08:07 AM EDT
R&D

Mi­croR­NA play­er Mi­Ra­gen bags $40M round and a pub­lic stock list­ing in re­verse merg­er

Arsalan Arif

Founder

Boul­der, CO-based Mi­Ra­gen Ther­a­peu­tics has found its way in­to the pub­lic mar­kets, re­verse merg­ing with strug­gling Sig­nal Ge­net­ics and gain­ing a $40 mil­lion round …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times